Skip to main content

Amadeus Capital Partners — Portfolio, Page 2

Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.

80
Companies
$2.0B
Total invested
$25.6M
Avg. check
57
Industries
Software 12Artificial Intelligence (AI) 8Biotechnology 6Machine Learning 6Information Technology 5Health Care 4+51 more
Founder contacts

Verified emails & LinkedIn for founders across this portfolio.

jane@on●●●●●●●.com
linkedin.com/in/●●●●●●
Verified contacts, updated monthly
Get instant access →

Portfolio companies

Showing 25–48 of 80
Natrox
December 2024

Natrox is a wound care company that offers innovative technologies for healthcare professionals for chronic wounds.

Health Care · Cambridge$33.0M Series C
PhoreMost
September 2024

PhoreMost is a new-model drug discovery company based in Cambridge, UK.

Biopharma · Cambridge$12.0M Series B
Riverlane
August 2024

Riverlane develops software solutions to harness the power of quantum computers for practical applications.

Computer · Cambridge$75.0M Series C
planqc
July 2024

creating quantum computers atom by atom

Computer · Munich$32.5M Series A
Periphery
May 2024

Embedded AI threat management for critical industrial and defence embedded technologies.

Cyber Security · Leeds$1.7M Pre-Seed
Secondmind
November 2023

Machine learning for automotive innovators

Artificial Intelligence (AI) · Cambridge$16.0M Venture - Series Unknown
Sprout.ai
October 2023

AI-powered insurance automation delivering fast, fair, accurate and explainable claims decisions.

Artificial Intelligence (AI) · London$6.6M Venture - Series Unknown
Cambridge Touch Technologies Ltd.
May 2023

Pressure Sensitive Multi-Touch for Next-Generation Smart Devices including Smartphones, Tablets, Automotive and Industrial

Automotive · Cambridge$5.1M Series B
Tenzo
May 2023

Bring your entire tech stack together in one place, get meaningful recommendations on how to hit your targets.

Developer APIs · London$5.0M Series A
Seldon
March 2023

Seldon is a machine learning deployment platform.

Artificial Intelligence (AI) · London$20.0M Series B
Atto
February 2023

At Atto, we provide instant insights into the financial behaviours of borrowers through real-time transaction data.

Banking · Edinburgh$9.5M Series A
Doctify
January 2023

Doctify is a global healthcare platform building a trusted network of verified providers with unmatched credibility.

Consumer Reviews · London$10.0M Venture - Series Unknown
V7
November 2022

V7 is a powerful AI training data platform used to produce high-quality image and video data annotations to train computer vision models.

Artificial Intelligence (AI) · London$33.0M Series A
Improbable
October 2022

Improbable is a technology company that provides a metaverse platform designed to offer virtual gaming experiences.

Content Creators · London$100.0M Venture - Series Unknown
Unlikely AI
September 2022

Unlikely AI is a talented group that is approaching artificial intelligence from a daring, fresh angle.

Artificial Intelligence (AI) · London$20.3M Seed
Ori Biotech
January 2022

Ori Biotech is a developer of a manufacturing platform used to help patients get access to lifesaving treatments.

Biotechnology · London$100.0M Series B
brytlyt
December 2021

Brytlyt provides transformational serverless acceleration for analytics

Analytics · Maidstone$5.0M Series A
Synthace
November 2021

Synthace is a SaaS Life Sciences R&D Digital Experiment Platform.

Biotechnology · London$35.0M Series C
Charco Neurotech
November 2021

Charco Neurotech is a medical technology company that develops non-invasive wearable devices.

Biotechnology · Cambridge$9.9M Seed
Sphere Bio
October 2021

Sphere Bio specializes in tools for single cell analysis and isolation, facilitating discovery in the biotech field.

Biotechnology · Cambridge$41.4M Venture - Series Unknown
SenseOn
September 2021

SenseOn provides accurate and context-rich alerts.

Artificial Intelligence (AI) · London$20.0M Series A
Refute
February 2026

Refute is a technology company that builds software designed to detect, analyze, and combat digital misinformation across online platforms.

Artificial Intelligence (AI) · London$6.8M Seed
Nuclera
January 2026

Nuclera offers a protein prototyping system to accelerate drug discovery by making proteins readily available to researchers.

Biotechnology · Cambridge$12.0M Series C
Photonic
January 2026

Photonic is a quantum technology company that builds scalable quantum computing systems and quantum networking solutions for commercial use.

Hardware · Vancouver$130.8M Series Unknown

Where Amadeus Capital Partners invests

Software12
Artificial Intelligence (AI)8
Biotechnology6
Machine Learning6
Information Technology5
Health Care4

About Amadeus Capital Partners's portfolio

How many companies has Amadeus Capital Partners invested in?▸

Amadeus Capital Partners has invested in 80 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.

What industries does Amadeus Capital Partners invest in?▸

Amadeus Capital Partners's top investment sectors include Software, Artificial Intelligence (AI), Biotechnology, Machine Learning, Information Technology. The firm invests across 57 different industry categories.

What is Amadeus Capital Partners's largest investment?▸

Among tracked funding rounds, Photonic received $130.8M in a Series Unknown round. Amadeus Capital Partners's total known invested capital is $2.0B.

What is the average investment size for Amadeus Capital Partners?▸

Amadeus Capital Partners's average investment size is $25.6M across its portfolio of 80 companies.

What are Amadeus Capital Partners's most recent investments?▸

Recent Amadeus Capital Partners portfolio additions include Natrox, PhoreMost, Riverlane, planqc, Periphery. These companies were founded in 2020 or later.

Reach the founders behind these 80 companies
Verified emails and LinkedIn profiles, updated monthly.
Get instant access →